microcapsuled enrofloxacin - Neo-enfl

Pruduct Name: Microcapsuled Enrofloxacin(10%)
Trade Name: Neo-enfx
Trademark:
Marketing Status: Rx
Key Component:
Enrofloxacin micropowder (10%);
Specific plant-based lipidic coating.
Description: White granule (60±20 mesh)
Production Methods:
Intelligent Microcapsule Technology (IM)
Features:
Acid & alkali resistant and hydrophobic
Never bitter or irritant in mouth / stomach
Sustained released in the small intestine
Well mixed with feed because of rough surface
Lightproof coating and box avoiding photolysis
Pharmacological Action:
Just like enrofloxacin powder, Neo-enfx has antibacterial activity against a broad spectrum of gram-negative and gram-positive bacteria as follows: Pseudomonas aeruginosa, Klebsiella spp., Escherichia coli, Enterobacter, Campylobacter, Shigella, Salmonella, Aeromonas, Haemophilus, Proteus, Yersinia, Serratia, Vibrio, Brucella, Chlamydia trachomatis, Mycoplasma, Mycobacterium sp., Staphylococci(including penicillinase-producing and methicillin-resistant strains)
Variable activity against: streptococci
Ineffective against anaerobes
Adverse Reaction: No prescription
Indication:
Enrofloxacin Premix. Used to prevent and treat respiratory diseases, septic colibacillosis, malignant rhinitis, pasteurella, salmonellosis, staphylocosis, dysentery, endemic epidemic pneumonia, hydropsy, mastitis and so on.
Usage and Dosage: (eg. pig):
Prevention: 0.80~1.0 g/kg feed
Treatment: 1.0~1.5 g/kg feed
Using for 5 - 7 continuous days
Precaution:
Do not recommend long-term overuse in piglet to avoid potential cartilage abnormality.
Withdrawal Period: 7 days before the slaughter
Content Specification: 100g: 10g
Packing: 10kg
Storage: Sealed in cool and dry place
Validity: 24 months